In: The Journal of Infectious Diseases, 2016, vol. 213, no. 9, p. 1370-1379
|
In: European Journal of Pediatrics, 2015, vol. 174, no. 9, p. 1255-1262
|
In: EMBO molecular medicine, 2016, vol. 8, no. 4, p. 407-421
Currently available rabies post‐exposure prophylaxis (PEP) for use in humans includes equine or human rabies immunoglobulins (RIG). The replacement of RIG with an equally or more potent and safer product is strongly encouraged due to the high costs and limited availability of existing RIG. In this study, we identified two broadly neutralizing human monoclonal antibodies that represent a...
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2014, vol. 33, no. 11, p. 1967-1971
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2019, vol. 38, no. 5, p. 945–949
Our aim was to evaluate the prevalence of fosfomycin-resistant strains among ESBL- producing Escherichia coli isolates recovered from community patients in Switzerland. A total of 1225 ESBL-producing E. coli isolates were collected between 2012 and 2013 from a private and community laboratory. Fosfomycin resistance was assessed by using the novel rapid fosfomycin/E. coli NP test and agar...
|
In: European Journal of Clinical Microbiology and Infectious Diseases, 2006, vol. 25, no. 8, p. 535-536
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2009, vol. 28, no. 6, p. 647-653
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2012, vol. 31, no. 12, p. 3367-3374
|
In: Clinical Oral Investigations, 2009, vol. 13, no. 4, p. 369-373
|
In: Numerische Mathematik, 2005, vol. 100, no. 3, p. 441-456
|